How to Predict the Absorption Rate of New Chemical Entities

Posted: 02/22/2012

Current estimates indicate that 40% of drugs on the market place and 90% of APIs in development are poorly soluble. David Elder, Externalisation Director for GlaxoSmithKline and Pharma IQ Advisory Board Member, joins Andrea Charles from Pharma IQ, to discuss the ever-increasing numbers of poorly soluble drugs coming to market and utilising in silico and computational modelling to better predict absorption of new chemical entities.

To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

This interview was filmed at Pharma IQ's 7th Improving Solubility conference in June 2011.


Have Your Say
Rate this feature and give us your feedback in the comments section below